Michael Simonian, Ph.D., has over 30 years of experience in both basic research in academia and industry product development. Dr. Simonian is an owner of MHS Biotechnology Consulting, which is a company that provides consultation and on-site laboratory services to medical device, pharmaceutical and biotechnology companies that range from start-ups to established multinational companies. Dr. Simonian’s experience in the industry includes application and product development for scientific instrumentation and research and development for in vitro diagnostic kits for infectious diseases. His experiences with scientific instrumentation include high-performance chromatography, both gel, and capillary electrophoresis, and UV-visible spectrophotometers. Dr. Simonian has extensive experience both in academia and industry with animal cell culture by establishing primary cultures and use of cell culture lines. Recently, Dr. Simonian has developed and validated cell-based assays and immunoassays for medical device companies to be used in lot release testing. In addition, he has experience as a quality assurance internal auditor, root cause analysis of quality issues and risk analysis for new products. Dr. Simonian has a Ph.D. in biochemistry and formerly was on the faculty at the University of Iowa where he taught and did basic research. He is a member of the following professional societies: American Association for the Advancement of Science, American Association for Cancer Research, American Chemical Society (Division of Biological Chemistry), American Society for Biochemistry and Molecular Biology, and American Society for Cell Biology.